Serial MRE and PDFF at each time point in responders and non-responders. by Natthaya Chuaypen (6726911)

Correlation between protein abundances and R_5-20 z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (... by Spela Kokelj (8356644)

(Related to Fig 5B and 5C). Comparison of mean percentages of transfected cells with SGs calculated from three biological triplicates, showing the decrease in % as compared to wt N or the mutant N1a+N2b N. by Chiara Aloise (8374950)

Measured glucose concentration at time points 1, 5, 10 min, and 4h in 100 <i>μ</i>L incubations. by Hamidreza Arjmandi (19657263)

Survey periods in connection with the number of new infections and key points of the regulatory orders in Germany. by Julie Levacher (14485531)

S1 File - by Yonghui Zhang (279832)

Subjects:

Detailed information on field experiments. by Yonghui Zhang (279832)

Subjects:

List of symbols used in this study. by Yonghui Zhang (279832)

Subjects:

Data sources for calibration and evaluation. by Yonghui Zhang (279832)

Subjects:

Primary and secondary outcomes of the randomized clinical trial groups at 3 months and 12 months. by Teemu P. Hevonkorpi (11577571)

Subjects:

Baseline characteristics of 291 patients by randomization group. by Teemu P. Hevonkorpi (11577571)

Subjects:

Adverse events at 12-month follow-up by study group. by Teemu P. Hevonkorpi (11577571)

Subjects:

Participant flow diagram of the DRIFT trial. by Teemu P. Hevonkorpi (11577571)

Subjects:

Between-group differences of mean PRWE with 95% confidence intervals in primarily malaligned DRFs and early malaligned DRFs at 3-month and 12-month follow-up. by Teemu P. Hevonkorpi (11577571)

Subjects:

Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

nanoDSF apparent melting points. by Aleksi Sutinen (10039145)

Crude and adjusted analysis of the incidence of decreased glomerular filtration over the 6-year study period, considering Model 1 and Model 2. by Camila de Souza dos Santos (17721066)

Means and Cronbach’s alphas for 5C and VAX-measured vaccination attitudes over 12 months. by Allyson J. Gallant (9382396)

Optimal conditions for mean germination time. by Ahad Asghari (20615202)

“…The results revealed that increasing PAW levels up to 0.18 min/mL led to an increase in seed germination percentage, seedling weight (both fresh and dry), seedling length, vigor indexes A and B, and water uptake and decreasing mean germination time. …”